• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

FDA approves first glucose sensing tech that doesn’t require routine finger sticks

September 28, 2017 By Sarah Faulkner

AbbottAbbott (NYSE:ABT) said yesterday that the FDA approved its FreeStyle Libre Flash glucose monitoring system as a replacement for blood glucose monitoring for adults with diabetes.

The company’s technology doesn’t require finger stick calibration and eliminates the need for users to routinely stick their fingers for samples.

The blood glucose monitor replacement indication means that people with diabetes can make treatment decisions based on information from the FreeStyle Libre device, according to Abbott.

The system includes a sensor the size of two stacked quarters that’s placed on the back of the upper arm. Users can capture real-time glucose readings using a hand-held reader that picks up signals from the sensor. Users can also review eight hours of glucose history and keep an eye out for glucose level trends, monitoring fluctuations throughout the day.

“Today, we are celebrating a breakthrough moment for people with diabetes in the U.S.—an end to the worry and hassles associated with routine finger sticks which have been the standard of glucose testing for more than 40 years,” Jared Watkin, SVP of Abbott’s diabetes care business, said in prepared remarks.

“At Abbott, we believe that FreeStyle Libre will transform diabetes management and we’re proud to be at the forefront of innovation that empowers people to take control of their health to live their best lives.”

Clinical trials and real-world evidence from 50,000 FreeStyle Libre users have shown that people who use Abbott’s system test their glucose levels, on average, 15 times each day. Previous work demonstrated that people who scan more frequently spend less time in hypoglycemia or hyperglycemia, while maintaining improved average glucose levels.

“Diabetes management requires active participation by the patient. Regular monitoring of glucose levels is especially crucial among patients being treated with insulin,” Dr. Maria Tulpan, from Lenox Hill Hospital in New York, N.Y., added. 

“What we see with the FreeStyle Libre system is patients gaining a better understanding of the impact of food, exercise and specific medications on their glucose levels due to availability of the data, which is important in the day-to-day management of diabetes and for behavioral changes towards improved diabetes control.”

Filed Under: Diabetes, Featured, Food & Drug Administration (FDA), Pharmaceuticals, Regulatory/Compliance, Wall Street Beat Tagged With: abbott

IN CASE YOU MISSED IT

  • Flat Medical partners with Mercury Medical on smart syringe distribution
  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7

Reader Interactions

Comments

  1. Nena says

    July 17, 2018 at 9:57 pm

    Where can you buy it and what is the price. Thank you

  2. Kenneth E Bradley says

    January 10, 2019 at 9:44 am

    where can I get the new either purchase or free ?

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS